Influence of a type 2 diabetes associated prostaglandin E synthase 2 polymorphism on blood prostaglandin E2 levels

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 80, Issue 4, 2009, Pages 185-188

  Boomgaarden, I ^a   Bosy Westphal, A ^a   Muller M J ^a   Doring F ^a  

^a UNIVERSITY OF KIEL   (Germany)

Author keywords

KOPS cohort; Polymorphism; Prostaglandin E2; PTGES2; Whole blood

Indexed keywords

6 OXOPROSTAGLANDIN F1 ALPHA; ARACHIDONIC ACID; ARGININE; BIOLOGICAL MARKER; HISTIDINE; PROSTAGLANDIN E SYNTHASE; PROSTAGLANDIN E SYNTHASE 2; PROSTAGLANDIN E2; UNCLASSIFIED DRUG;

ADULT; AGED; ARACHIDONIC ACID METABOLISM; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIET RESTRICTION; DNA POLYMORPHISM; FEMALE; GENE; GENETIC ASSOCIATION; GENOTYPE; HETEROZYGOTE DETECTION; HUMAN; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROSTAGLANDIN E SYNTHASE 2 GENE; PROTEIN BLOOD LEVEL; SEX DIFFERENCE;

ADULT; AGED; DIABETES MELLITUS, TYPE 2; DINOPROSTONE; FASTING; FEMALE; HUMANS; INTRAMOLECULAR OXIDOREDUCTASES; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; SEX FACTORS;

EID: 67349157985     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.plefa.2009.02.001     Document Type: Article

References (23)

1. Murakami M., and Kudo I. Recent advances in molecular biology and physiology of the prostaglandin E2-biosynthetic pathway. Prog. Lipid Res. 43 (2004) 3-35
2. Milton A.S., and Wendlandt S. Effects on body temperature of prostaglandins of the A, E and F series on injection into the third ventricle of unanaesthetized cats and rabbits. J. Physiol. 218 (1971) 325-336
3. Ushikubi F., Segi E., Sugimoto Y., et al. Impaired febrile response in mice lacking the prostaglandin E receptor subtype EP3. Nature 395 (1998) 281-284
4. Hittelman K.J., and Butcher R.W. Effects of antilipolytic agents and alpha-adrenergic antagonists on cyclic AMP metabolism in hamster white adipocytes. Biochim. Biophys. Acta 316 (1973) 403-410
5. Fain J.N., Leffler C.W., and Bahouth S.W. Eicosanoids as endogenous regulators of leptin release and lipolysis by mouse adipose tissue in primary culture. J. Lipid Res. 41 (2000) 1689-1694
6. Fain J.N., Leffler C.W., Bahouth S.W., Rice A.M., and Rivkees S.A. Regulation of leptin release and lipolysis by PGE2 in rat adipose tissue. Prostaglandins Other Lipid Mediat. 62 (2000) 343-350
7. Laychock S.G., and Bilgin S. Calcium mobilization, prostaglandin E2 and alpha 2-adrenoceptor modulation of glucose utilization and insulin secretion in pancreatic islets. Biochem. Pharmacol. 38 (1989) 2511-2520
8. Oshima H., Taketo M.M., and Oshima M. Destruction of pancreatic beta-cells by transgenic induction of prostaglandin E2 in the islets. J. Biol. Chem. 281 (2006) 29330-29336
9. Ogorochi T., Ujihara M., and Narumiya S. Purification and properties of prostaglandin H-E isomerase from the cytosol of human brain: identification as anionic forms of glutathione S-transferase. J. Neurochem. 48 (1987) 900-909
10. Watanabe K., Kurihara K., and Suzuki T. Purification and characterization of membrane-bound prostaglandin E synthase from bovine heart. Biochim. Biophys. Acta 1439 (1999) 406-414
11. Tanioka T., Nakatani Y., Semmyo N., Murakami M., and Kudo I. Molecular identification of cytosolic prostaglandin E2 synthase that is functionally coupled with cyclooxygenase-1 in immediate prostaglandin E2 biosynthesis. J. Biol. Chem. 275 (2000) 32775-32782
12. Fisher E., Nitz I., Lindner I., et al. Candidate gene association study of type 2 diabetes in a nested case-control study of the EPIC-Potsdam cohort-role of fat assimilation. Mol. Nutr. Food Res. 51 (2007) 185-191
13. Nitz I., Fisher E., Grallert H., et al. Association of prostaglandin E synthase 2 (PTGES2) Arg298His polymorphism with type 2 diabetes in two German study populations. J. Clin. Endocrinol. Metab. 92 (2007) 3183-3188
14. Lindner I., Helwig U., Rubin D., et al. Prostaglandin E synthase 2 (PTGES2) Arg298His polymorphism and parameters of the metabolic syndrome. Mol. Nutr. Food Res. 51 (2007) 1447-1451
15. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., and Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 (1985) 412-419
16. Bosy-Westphal A., Onur S., Geisler C., et al. Common familial influences on clustering of metabolic syndrome traits with central obesity and insulin resistance: the Kiel obesity prevention study. Int. J. Obes. (Lond.) 31 (2007) 784-790
17. Yamada T., Komoto J., Watanabe K., Ohmiya Y., and Takusagawa F. Crystal structure and possible catalytic mechanism of microsomal prostaglandin E synthase type 2 (mPGES-2). J. Mol. Biol. 348 (2005) 1163-1176
18. Miyagi M., Morishita M., and Iwamoto Y. Effects of sex hormones on production of prostaglandin E2 by human peripheral monocytes. J. Periodontol. 64 (1993) 1075-1078
19. Marcus C., Sonnenfeld T., Karpe B., Bolme P., and Arner P. Inhibition of lipolysis by agents acting via adenylate cyclase in fat cells from infants and adults. Pediatr. Res. 26 (1989) 255-259
20. Griffin M.E., Marcucci M.J., Cline G.W., et al. Free fatty acid-induced insulin resistance is associated with activation of protein kinase C theta and alterations in the insulin signaling cascade. Diabetes 48 (1999) 1270-1274
21. Boden G., She P., Mozzoli M., et al. Free fatty acids produce insulin resistance and activate the proinflammatory nuclear factor-kappaB pathway in rat liver. Diabetes 54 (2005) 3458-3465
22. Despres J.P., Allard C., Tremblay A., Talbot J., and Bouchard C. Evidence for a regional component of body fatness in the association with serum lipids in men and women. Metabolism 34 (1985) 967-973
23. Enzi G., Gasparo M., Biondetti P.R., Fiore D., Semisa M., and Zurlo F. Subcutaneous and visceral fat distribution according to sex, age, and overweight, evaluated by computed tomography. Am. J. Clin. Nutr. 44 (1986) 739-746